JB Chemicals & Pharmaceuticals Limited — Others, 28-06-2025: Appointment

J.B. Chemicals & Pharmaceuticals has announced a board meeting to approve the re-appointment of Mr. Nikhil Ashokkumar Chopra as CEO and Whole-time Director for a five-year term starting October 5, 2025, subject to shareholder approval. Chopra has led the company since 2020, driving a 16% growth rate—well above the industry average—through strategic acquisitions and expansion into key therapies like cardiology and ophthalmology. Under his leadership, JB Pharma nearly doubled its revenue to over INR 3000 Cr in FY23 and ranks among the top players in several segments. He is also recognized for advancing digital marketing and sustainability initiatives.